Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06043310 · ClinicalTrials.gov registry record
Estrogen and Microvascular Function
A clinical trial of Cardiovascular Diseases and Estrogen, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT06043310 is a study of Cardiovascular Diseases and Estrogen that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 45 participants, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06043310, a study of Cardiovascular Diseases and Estrogen, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn how long-term use of estrogen affects blood vessels in healthy adults. Participants will: * give one blood draw of 5 mL * have one Dexa Scan taken to measure adipose and muscle mass * have a camera placed under the tongue to take pictures of blood vessels * have 2 laser Doppler microdialysis catheters placed on the forearm to monitor blood vessels before and after local drug infusion Researchers will compare blood vessel function of those who take estrogen to those who do not.
Conditions Studied
Interventions
- DRUG Acetylcholine
- DRUG Sodium Nitroprusside
- DRUG Nω-nitro-L-arginine methyl ester (L-NAME)
Study Locations (1)
Wisconsin
- Froedtert Hospital - Wauwatosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2031-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06043310
The ClinicalTrials.gov registry entry for NCT06043310 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,974-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (100% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which Acetylcholine is the first listed.
NCT06043310 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06043310 about?
NCT06043310 is a clinical study titled "Estrogen and Microvascular Function". The goal of this study is to learn how long-term use of estrogen affects blood vessels in healthy adults. Participants will: * give one blood draw of 5 mL * have one Dexa Scan taken to measure adipose and muscle mass * have a camera placed under the tongue to take pictures of blood vessels * have ...
What is the current status of trial NCT06043310?
This trial is currently active not recruiting. The enrollment target is 45 participants. The study started on 2023-10-12. Estimated completion is 2031-12.
What conditions does trial NCT06043310 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Estrogen, Microvasculature, Oral Contraceptive Use.
What interventions are being tested in trial NCT06043310?
The interventions under investigation include: Acetylcholine (DRUG), Sodium Nitroprusside (DRUG), Nω-nitro-L-arginine methyl ester (L-NAME) (DRUG).
Who is sponsoring clinical trial NCT06043310?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06043310 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
RECRUITING · Phase 1
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)
RECRUITING
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.